Here are the top hepatitis stories by pageviews this year:

1. FDA OKs Major New Hepatitis C Drug, Sovaldi (Sofosbuvir)
Posted: December 6

2. 100% Cure Rate for Hep C With Sofosbuvir, Ledipasvir Combo Therapy
Posted: March 13

3. Simeprevir and Sofosbuvir Cure Hep C Genotype 1 at High Rates
Posted: November 7

4. Sofosbuvir and Ledipasvir Boast High Cure Rates for Hep C
Posted: May 13

5. Gilead Applies for FDA Approval of Sofosbuvir, First Interferon-Free Hep C Regimen
Posted: April 11

6. Gilead Reports Promising New Data on Sofosbuvir and GS-5885
Posted: January 14

7. Sofosbuvir and Ribavirin Succeed in Hard-to-Treat Hep C Group
Posted: September 3

8. Gilead Reports Promising New Data on Sofosbuvir and GS-5885
Posted: January 14

9. Reducing Ribavirin Dose Works Well in AbbVie Hep C Combo
Posted: July 29

10. Sofosbuvir and Ribavirin Cure 90% of Most Types of Hep C
Posted: May 1

11. Faldaprevir and Deleobuvir Cure 95% of Hep C Genotype 1b
Posted: May 1

12. FDA Approves New Hep C Drug: Janssen’s Olysio (Simeprevir)
Posted: November 25

13. Aggressive Flu Virus Spreading Early This Winter
Posted: January 11

14. AbbVie Hep C Combo Cures Nearly All Genotype 1b’s
Posted: June 17

15. More Good News From AbbVie’s Five-Drug Hep C Combo
Posted: April 26

16. Post-Cure Hep C Reinfection Is Common Among Prisoners
Posted: July 22

17. Fibroscan Predicts Liver Disease Progression Better Than Biopsy
Posted: July 15

18. Sofosbuvir, Daclatasvir Combo Cures 100% in Hep C Trial
Posted: April 29

19. Simeprevir and Sofosbuvir Achieve High Cure Rates in Hep C Null-Responders
Posted: March 11

20. Most Docs Tell Their Hep C Patients: Wait for New Drugs
Posted: June 3